A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine
After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 y...
Saved in:
Main Authors: | , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/28271 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.28271 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.282712018-09-13T14:08:21Z A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine Krisana Pengsaa Kriengsak Limkittikul Arunee Sabchareon Churdchoo Ariyasriwatana Pornthep Chanthavanich Phanosri Attanath Claudius Malerczyk Mahidol University Queen Sirikit National Institute of Child Health Novartis Vaccines and Diagnostics Medicine After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins. 2018-09-13T07:08:21Z 2018-09-13T07:08:21Z 2009-01-01 Article Pediatric Infectious Disease Journal. Vol.28, No.4 (2009), 335-337 10.1097/INF.0b013e3181906351 15320987 08913668 2-s2.0-65649111203 https://repository.li.mahidol.ac.th/handle/123456789/28271 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=65649111203&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Krisana Pengsaa Kriengsak Limkittikul Arunee Sabchareon Churdchoo Ariyasriwatana Pornthep Chanthavanich Phanosri Attanath Claudius Malerczyk A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
description |
After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. Copyright © 2009 by Lippincott Williams & Wilkins. |
author2 |
Mahidol University |
author_facet |
Mahidol University Krisana Pengsaa Kriengsak Limkittikul Arunee Sabchareon Churdchoo Ariyasriwatana Pornthep Chanthavanich Phanosri Attanath Claudius Malerczyk |
format |
Article |
author |
Krisana Pengsaa Kriengsak Limkittikul Arunee Sabchareon Churdchoo Ariyasriwatana Pornthep Chanthavanich Phanosri Attanath Claudius Malerczyk |
author_sort |
Krisana Pengsaa |
title |
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
title_short |
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
title_full |
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
title_fullStr |
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
title_full_unstemmed |
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
title_sort |
three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old thai children, concomitantly with japanese encephalitis vaccine |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/28271 |
_version_ |
1763487528147484672 |